Reevaluating Cell and Gene Therapy Development: The industry considers applying automation and digitalization lessons learned during the COVID-19 pandemic to enhance workflows.
| Publicado en: | BioPharm International Vol. 34; no. 9; pp. 18 - 20 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
MJH Life Sciences
Sep2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| Descripción no disponible. |